ARTICLE | Company News
Cambridge Antibody Technology Ltd., Genentech, Peptide deal
August 7, 1995 7:00 AM UTC
GNE (South San Francisco) received a non-exclusive license to Cambridge Antibody Technology's antibody libraries and associated technology for research purposes. GNE invested $2 million in privately h...